HFA Premium Access

The usefulness of end-expiratory oxygen partial pressure as a prognostic indicator in patients with heart failure with reduced ejection fraction

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Congress Presentation

About the speaker

Doctor Taisuke Nakade

Juntendo University Graduate School of Medicine, Tokyo (Japan)
0 follower

7 more presentations in this session

SGLT2 inhibitors in heart failure with reduced ejection fraction without diabetes mellitus: why are patients outside the magic circle?

Speaker: Doctor D. Santoro (Bari, IT)


Integrated transcriptomic and regulatory RNA sequencing and machine-learning driven analyses identify molecular signatures underlying human heart failure

Speaker: Doctor J. Gulia (Bengaluru, IN)


Impact of prolonged use of angiotensin receptor-neprilysin inhibitors versus angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients with heart failure reduced ejection frac

Speaker: Assistant Professor B. PARK (Daegu, KR)


Cardiac amyloidosis patients with reduced ejection fraction have an increase morbimortality

Speaker: Doctor F. Bauer (Rouen, FR)


Ivabradine improves survival in children with severe chronic heart failure

Speaker: Doctor R. Adorisio (Rome, IT)


Access the full session

Heart failure with reduced ejection fraction (HFrEF) 2

Speakers: Doctor T. Nakade, Doctor D. Santoro, Doctor J. Gulia, Assistant Professor B. PARK, Doctor F. Bauer...

About the event


Heart Failure 2023

20 May - 23 May 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb